Literature DB >> 9338476

Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.

M Imbriaco1, S D Yeh, H Yeung, J J Zhang, J H Healey, P Meyers, A G Huvos, S M Larson.   

Abstract

BACKGROUND: The degree of tumor necrosis after preoperative intravenous chemotherapy is likely to be an indicator of prognosis for patients with primary osteosarcoma. This study was undertaken to evaluate the efficacy of thallium-201 (Tl-201) scintigraphy in assessing response to chemotherapy in patients with osteosarcoma and to correlate the findings with the degree of tumor necrosis assessed histologically.
METHODS: Twenty-four patients with biopsy-proven osteosarcoma underwent Tl-201 imaging before and immediately after preoperative intravenous chemotherapy. The maximum pixel counts taken over the tumor divided by those taken of a background region yielded a tumor-to-background ratio. The percentage of change in the tumor-to-background ratio before and after chemotherapy, defined as the alteration ratio, was correlated with the percentage of tumor necrosis. The percentages of tumor necrosis were classified into 4 grades: Grade 1, <50%; Grade 2, 50-89%; Grade 3, 90- 99%; Grade 4, 100%.
RESULTS: Three patients with Grade 1 histologic response had an alteration ratio of 31% +/- 4 (mean +/- standard deviation). Three patients with Grade 2 response had an alteration ratio of 76% +/- 9. Nine patients with Grade 3 response had an alteration ratio of 84% +/- 11. Nine patients with Grade 4 response had an alteration ratio of 96% +/- 5. These ratios correlated well with the histologic grades (P < 0.001).
CONCLUSIONS: The results of this study suggest that Tl-201 scintigraphy is a powerful tool in the evaluation of tumor response to chemotherapy in patients with osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338476

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Estimation of potential excess cancer incidence in pediatric 201Tl imaging.

Authors:  Sue C Kaste; George L Waszilycsak; M Beth McCarville; Najat C Daw
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

2.  Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.

Authors:  Yoshiko Hayashida; Toshitake Yakushiji; Kazuo Awai; Kazuhiro Katahira; Yoshiharu Nakayama; Osamu Shimomura; Mika Kitajima; Toshinori Hirai; Yasuyuki Yamashita; Hiroshi Mizuta
Journal:  Eur Radiol       Date:  2006-08-15       Impact factor: 5.315

3.  Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography.

Authors:  Shinji Miwa; Toshiharu Shirai; Junichi Taki; Hisashi Sumiya; Hideji Nishida; Katsuhiro Hayashi; Akihiko Takeuchi; Akishi Ooi; Hiroyuki Tsuchiya
Journal:  Int J Clin Oncol       Date:  2011-02-18       Impact factor: 3.402

Review 4.  The role of SPET and PET in monitoring tumour response to therapy.

Authors:  Chariklia Giannopoulou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-14       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.